"The Report Womens Health
Cluster Drug Development Pipeline Review, 2017 provides information
on pricing, market analysis, shares, forecast, and company profiles
for key industry participants. - MarketResearchReports.biz"
Description
This report provides an overview
of the women’s health pipeline landscape. The report provides
comprehensive information on the therapeutics under development and
key players involved in therapeutic development for female
infertility, polycystic ovarian syndrome and endometriosis, and also
features dormant and discontinued projects.
The three key disorders covered in
this report are largely driven by dysfunction of the endocrine
system, but have a broad range of effects. Infertility is defined as
the inability to get pregnant after a year of unprotected
intercourse. Female infertility can be also be caused by a number of
factors, which include damage to fallopian tubes, hormonal causes,
cervical causes, uterine causes, unexplained infertility. Polycystic
ovary syndrome (PCOS) is a common hormonal disorder among women of
reproductive age. Symptoms include menstrual abnormality, acne,
thinning hair on the scalp, weight gain, excess androgen and
polycystic ovaries. Finally, endometriosis is an often painful
disorder in which tissue that normally lines the inside of uterus
(the endometrium) grows outside the uterus (endometrial implant).
Symptoms include pelvic pain, menstrual cramps, inflammation,
infertility and abnormal bleeding.
Get Sample Copy Of this Report
@
The size of these pipelines ranges
from 12 in PCOS to 87 in female infertility. The most common types of
therapy being developed in these diseases act on hormone receptors,
reflecting the hormone-driven pathophysiology of this disease area.
However, particularly in polycystic ovarian syndrome, a broader range
of molecular targets, such as intracellular protein kinases,
chemokine receptors and other cell signaling components are also
targeted.
Scope
Which companies are the most
active within the pipeline for women’s health therapeutics?
Which pharmaceutical approaches
are the most prominent at each stage of the pipeline and within each
indication?
To what extent do universities and
institutions play a role within this pipeline, compared to
pharmaceutical companies?
What are the most important R&D
milestones and data publications to have happened in the field of
women’s health therapeutics?
View Report @
http://www.marketresearchreports.biz/analysis/1070459
Reasons to buy
Understand the overall pipeline,
with an at-a-glance overview of all products in therapeutic
development for each indication
Assess the products in development
in granular detail, with an up-to-date overview of each individual
pipeline program in each indication, and a comprehensive picture of
recent updates and milestones for each
Analyze the companies,
institutions and universities currently operating in the pipeline,
and the products being fielded by each of these
Understand the composition of the
pipeline in terms of molecule type, molecular target, mechanism of
action and route of administration
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment